Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Goldenwell Biotech (GWLL) Interest Expenses (2020 - 2025)

Goldenwell Biotech (GWLL) has disclosed Interest Expenses for 4 consecutive years, with $2100.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses changed 0.0% year-over-year to $2100.0, compared with a TTM value of $8400.0 through Sep 2025, up 33.33%, and an annual FY2024 reading of $8400.0, up 447.23% over the prior year.
  • Interest Expenses was $2100.0 for Q3 2025 at Goldenwell Biotech, roughly flat from $2100.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $2100.0 in Q1 2024 and bottomed at -$1272.0 in Q4 2021.
  • Average Interest Expenses over 3 years is $1633.3, with a median of $2100.0 recorded in 2024.
  • The sharpest move saw Interest Expenses crashed 3161.54% in 2021, then changed 0.0% in 2025.
  • Year by year, Interest Expenses stood at -$1272.0 in 2021, then skyrocketed by 265.09% to $2100.0 in 2024, then changed by 0.0% to $2100.0 in 2025.
  • Business Quant data shows Interest Expenses for GWLL at $2100.0 in Q3 2025, $2100.0 in Q2 2025, and $2100.0 in Q1 2025.